Biogen <BIIB.O>: Piper Sandler Raises Target Price to $245 From $225
BIIB•Related News
Envista Holdings Corporation <NVST.N>: JP Morgan raises to Overweight from Neutral; raises target price to $32 from $29
NVST•
HUTCHMED licenses KRAS-EGFR antibody conjugate HMPL-A830 to GSK for USD 110 million upfront
HCM•
Goldman Sachs sees Venezuela crude output rising, but return to pre-2018 levels unlikely
CVX•
Snowflake Inc. <SNOW.N>: JP Morgan Raises Target Price to $426 From $285
SNOW•
Hutchmed Announces Licensing Agreement With GSK For Kras-Egfr-Antibody Conjugate Cancer Therapy
HCM•